The Wayback Machine - http://web.archive.org/web/20240310185934/https://finance.yahoo.com/news/
Advertisement
U.S. markets closed

Latest Financial and Business News

  • Image
    Business
    Reuters

    Nvidia is sued by authors over AI use of copyrighted works

    Nvidia, whose chips power artificial intelligence, has been sued by three authors who said it used their copyrighted books without permission to train its NeMo AI platform. Brian Keene, Abdi Nazemian and Stewart O'Nan said their works were part of a dataset of about 196,640 books that helped train NeMo to simulate ordinary written language, before being taken down in October "due to reported copyright infringement." In a proposed class action filed on Friday night in San Francisco federal court, the authors said the takedown reflects Nvidia's having "admitted" it trained NeMo on the dataset, and thereby infringed their copyrights.

  • Image
    World
    Associated Press Finance

    Police remove 34 bodies from English funeral home and arrest 2 for fraud and preventing burial

    Nearly three dozen bodies were removed from a funeral home in northern England, and a man and woman were arrested Sunday on suspicion of fraud and preventing a lawful burial, police said. Humberside Police announced the developments after five days of investigation at three branches of Legacy Funeral Directors in Hull and East Yorkshire. Assistant Chief Constable Thom McLoughlin said 34 bodies had been taken to a mortuary in Hull for identification.

  • Image
    Business
    Reuters

    India's Serum looks beyond COVID with new vaccines for malaria, dengue

    The CEO of the world's biggest vaccine maker, Serum Institute of India, said the company has bolstered its manufacturing ahead of launches over the next few years of shots against diseases like malaria and dengue by repurposing facilities used to make COVID-19 immunizations. With COVID manufacturing scaled back as demand ebbs, the company is using those facilities to instead manufacture its newer shots, which it estimates will boost total production by two and a half billion doses, CEO Adar Poonawalla said in an interview. Serum produces AstraZeneca's COVID-19 vaccine under the brand name Covishield in India, and also makes Novavax's protein-based COVID shots.